Clinical Trial Update: Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for PTI-808 focusing on safety, tolerability, and pharmacokinetics in healthy volunteers and adults with cystic fibrosis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• PTI-808

Snippet

Sponsor: Proteostasis Therapeutics, Inc. | Conditions: Healthy Volunteer - Complete, Cystic Fibrosis - Complete | Phase 1, Phase 2 | Status: COMPLETED